Passive immunotherapy for influenza A H5N1 virus infection with equine hyperimmune globulin F(ab')2 in mice.
about
Current and future antiviral therapy of severe seasonal and avian influenzaAntibodies against viruses: passive and active immunizationH5N1 whole-virus vaccine induces neutralizing antibodies in humans which are protective in a mouse passive transfer modelPrevention and treatment of influenza with hyperimmune bovine colostrum antibodyProphylactic and therapeutic efficacy of human monoclonal antibodies against H5N1 influenzaRationale for treating human influenza infections by passive transfer of specific antibodies.Passive immunoprophylaxis and therapy with humanized monoclonal antibody specific for influenza A H5 hemagglutinin in miceInfluenza A/H5N1 infection: other treatment options and issues.Neutralizing human monoclonal antibody against H5N1 influenza HA selected from a Fab-phage display library.Generation, characterization and epitope mapping of two neutralizing and protective human recombinant antibodies against influenza A H5N1 viruses.Combination therapy using chimeric monoclonal antibodies protects mice from lethal H5N1 infection and prevents formation of escape mutants.Safety and immunogenicity of multiple and higher doses of an inactivated influenza A/H5N1 vaccine.Cross-protection of chicken immunoglobulin Y antibodies against H5N1 and H1N1 viruses passively administered in miceANTIVIRAL COMPOUNDS IN THE PIPELINE TO TACKLE H1N1 INFLUENZA INFECTION.A human antibody recognizing a conserved epitope of H5 hemagglutinin broadly neutralizes highly pathogenic avian influenza H5N1 viruses.Identification of a human monoclonal Fab with neutralizing activity against H3N2 influenza A strain from a newly constructed human Fab library.Epitope characterization of the protective monoclonal antibody VN04-2 shows broadly neutralizing activity against highly pathogenic H5N1.Clinical characteristics of 26 human cases of highly pathogenic avian influenza A (H5N1) virus infection in China.An antibody against a novel and conserved epitope in the hemagglutinin 1 subunit neutralizes numerous H5N1 influenza virusesProtective effect of different anti-rabies virus VHH constructs against rabies disease in mice.Passive immunization against highly pathogenic Avian Influenza Virus (AIV) strain H7N3 with antiserum generated from viral polypeptides protect poultry birds from lethal viral infection.Specific polyclonal F(ab')2 neutralize a large panel of highly pathogenic avian influenza A viruses (H5N1) and control infection in mice.Enhancement of antiviral activity of collectin trimers through cross-linking and mutagenesis of the carbohydrate recognition domain.Report of the 'mechanisms of lung injury and immunomodulator interventions in influenza' workshop, 21 March 2010, Ventura, California, USA.Production and purification of polyclonal antibody against F(ab')2 fragment of human immunoglobulin G.The role of adjuvant immunomodulatory agents for treatment of severe influenza.Patient-derived avian influenza A (H5N6) virus is highly pathogenic in mice but can be effectively treated by anti-influenza polyclonal antibodies.
P2860
Q24656164-1E879A1A-C47D-4A5D-9334-3173DDADDECBQ27489392-703C5436-6C81-4ED1-98F0-17818AC59C91Q28741304-F096E58D-64F0-4325-953E-BDAA0E2E683BQ28748705-A2881305-FEE5-4523-97BF-E4A064522BC2Q28757651-5A1D15BB-4E49-408B-A200-5205B0F8941CQ30230073-B8DE0F00-CA92-49FF-9285-39CC6C9DA25AQ30357432-C7A61758-2220-432D-9FDE-DB83C9C1352DQ30368453-AE53CA95-09D5-4E78-BDC3-D150F8C7E51BQ30372987-59EE587C-7D35-4EAD-AC54-B9AF284A3BDDQ30376814-F72B4877-5D57-4E2D-90F8-7FD5DB50680DQ30377663-C94C7C6C-D2F4-4BEA-B306-5F73960D998CQ30378572-0DEE3057-D2AD-4A8A-88A9-EBEA199E8D39Q30403137-E56AFC5A-ABE6-41BC-8973-07488E2D6084Q30404586-2933E400-500F-4F9B-914C-07139ED1EB10Q30411637-295BA1D2-0593-4CE6-93C1-C9DA1FA0D167Q33327547-F51C26E9-D844-4DFC-AECB-79A5F3605381Q33350700-B587294C-C665-4488-9D1B-94D496F8FA7DQ33361942-5F811397-61A6-4803-B946-FBAB174F03AAQ34046083-10B5C434-3215-40D9-9FB2-695AC293D092Q34408085-54BB7281-539D-4A7E-BBAC-2E30EAD437B3Q37064705-0AC0A425-AC5F-4C87-8FD7-ABD4D86398DAQ42228728-F7F99470-8B7E-4587-8FE5-066035B377BCQ42409222-C7281F6D-D0E9-4DE6-B578-D28B2FEE57BFQ46139825-8C021C36-72D5-433A-95A5-A8734C37DE63Q47443117-669E2853-9B31-4325-9379-95C35185F8D1Q47554935-EA662810-3E86-45C4-B9F6-DBA489E7268BQ55263258-53E88505-8CF4-477B-8DD6-3DA9896BA093
P2860
Passive immunotherapy for influenza A H5N1 virus infection with equine hyperimmune globulin F(ab')2 in mice.
description
2006 nî lūn-bûn
@nan
2006 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի մարտին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
name
Passive immunotherapy for infl ...... mune globulin F(ab')2 in mice.
@ast
Passive immunotherapy for infl ...... mune globulin F(ab')2 in mice.
@en
type
label
Passive immunotherapy for infl ...... mune globulin F(ab')2 in mice.
@ast
Passive immunotherapy for infl ...... mune globulin F(ab')2 in mice.
@en
prefLabel
Passive immunotherapy for infl ...... mune globulin F(ab')2 in mice.
@ast
Passive immunotherapy for infl ...... mune globulin F(ab')2 in mice.
@en
P2093
P2860
P356
P1433
P1476
Passive immunotherapy for infl ...... mune globulin F(ab')2 in mice.
@en
P2093
Bingyan Tan
Dingmei Zhang
Guoling Wang
Liping Ouyang
Xinbing Yu
Xinghua Pan
Zhongmin Guo
P2860
P2888
P356
10.1186/1465-9921-7-43
P577
2006-03-23T00:00:00Z
P5875
P6179
1049177130